<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00692276</url>
  </required_header>
  <id_info>
    <org_study_id>08-VISS-01</org_study_id>
    <nct_id>NCT00692276</nct_id>
  </id_info>
  <brief_title>Investigating Superion™ In Spinal Stenosis</brief_title>
  <official_title>A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VertiFlex, Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed prospective, multi-center, randomized clinical trial is designed to evaluate the&#xD;
      safety and effectiveness of the Superion™ ISS compared to the X-STOP® IPD® device in healthy&#xD;
      adults suffering from at least 6 months of moderate spinal stenosis symptoms who have been&#xD;
      unresponsive to conservative care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed prospective, multi-center, randomized clinical trial is designed to evaluate the&#xD;
      safety and effectiveness of the Superion™ ISS compared to the X-STOP® IPD® device in healthy&#xD;
      adults suffering from at least 6 months of moderate spinal stenosis symptoms who have been&#xD;
      unresponsive to conservative care. The study endpoint is the rate of overall subject success&#xD;
      at 24 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Subjects With Clinically Significant Improvement in Outcomes</measure>
    <time_frame>Baseline and 24 months</time_frame>
    <description>Where clinically significant improvement in outcomes compared to baseline, as determined by meeting the following:&#xD;
At least two of three domains of the Zurich Claudication Questionnaire (ZCQ) [validated, condition-specific patient-reported questionnaire that captures data in three distinct domains]&#xD;
Improvement in physical function by ≥0.5 points&#xD;
Improvement in symptom severity by ≥0.5 points&#xD;
&quot;Satisfied&quot; or &quot;somewhat satisfied&quot; as defined by a score of ≤ 2.5 points on the patient satisfaction domain&#xD;
No re-operations, revisions, removals or supplemental fixation at the index level(s)&#xD;
No major implant- or procedure-related complications:&#xD;
No dislodgement, migration, or deformation&#xD;
No new or persistent worsened neurological deficit at the index level&#xD;
No spinous process fractures&#xD;
No deep infection, death, or other permanent device attributed disability&#xD;
No clinically significant confounding treatments:&#xD;
No epidural injections or nerve block proc</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">391</enrollment>
  <condition>Lumbar Spinal Stenosis</condition>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interspinous Process Spacer Device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Interspinous Process Spacer Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Superion™ Interspinous Spacer</intervention_name>
    <description>Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>X-STOP® IPD® Device</intervention_name>
    <description>Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female subjects ≥ 45 years of age&#xD;
&#xD;
          -  Persistent leg/buttock/groin pain, with or without back pain, that is relieved by&#xD;
             flexion activities (example: sitting or bending over a shopping cart)&#xD;
&#xD;
          -  Diagnosis of degenerative spinal stenosis of the lumbar spine, defined as the&#xD;
             narrowing of the midline sagittal spinal canal (central) and/or narrowing between the&#xD;
             facet superior articulating process (SAP), the posterior vertebral margin (lateral&#xD;
             recess), and the nerve root canal (foraminal)&#xD;
&#xD;
          -  Must be able to sit for 50 minutes without pain and to walk 50 feet or more&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Axial back pain only&#xD;
&#xD;
          -  Fixed motor deficit&#xD;
&#xD;
          -  Diagnosis of lumbar spinal stenosis which requires any direct neural decompression or&#xD;
             surgical intervention other than those required to implant the control or experimental&#xD;
             device&#xD;
&#xD;
          -  Unremitting pain in any spinal position&#xD;
&#xD;
          -  Significant peripheral neuropathy or acute denervation secondary to radiculopathy&#xD;
&#xD;
          -  Lumbar spinal stenosis at more than two levels determined pre-operatively to require&#xD;
             surgical intervention&#xD;
&#xD;
          -  Significant instability of the lumbar spine as defined by 3mm translation or 5 degrees&#xD;
             angulation&#xD;
&#xD;
          -  Sustained pathologic fractures of the vertebrae or multiple fractures of the vertebrae&#xD;
             and/or hips&#xD;
&#xD;
          -  Spondylolisthesis or degenerative spondylolisthesis greater than grade 1.0 (on a scale&#xD;
             of 1 to 4)&#xD;
&#xD;
          -  Spondylolysis (pars fracture)&#xD;
&#xD;
          -  Morbid obesity, defined as Body Mass Index (BMI) greater than 40kg/m2&#xD;
&#xD;
          -  Insulin-dependent diabetes mellitus&#xD;
&#xD;
          -  Prior surgery of the lumbar spine&#xD;
&#xD;
          -  Cauda equina syndrome (defined as neural compression causing neurogenic bowel or&#xD;
             bladder dysfunction)&#xD;
&#xD;
          -  Infection in the disc or spine, past or present&#xD;
&#xD;
          -  Paget's disease at involved segment or metastasis to the vertebra, osteomalacia, or&#xD;
             other metabolic bone disease&#xD;
&#xD;
          -  Tumor in the spine or a malignant tumor except for basal cell carcinoma&#xD;
&#xD;
          -  Involved in pending litigation of the spine or worker's compensation related to the&#xD;
             back&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona Center for Neurosurgery</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tucson Orthopaedic Institute</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>D.I.S.C. Sports and Spine Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tower Orthopaedics and Sports Medicine/ Institute for Advanced Spinal Research</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orange County Neurosurgical Associates</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653-3665</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brain and Spine Research Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Pain Medicine Consultants/Pacific Surgery Center</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital- The Spine Center- Anshutz Outpatient Pavilion</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durango Orthopedic Associates, P.C./Spine Colorado</name>
      <address>
        <city>Durango</city>
        <state>Colorado</state>
        <zip>81301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colorado Spine And Scoliosis Institute</name>
      <address>
        <city>Littleton</city>
        <state>Colorado</state>
        <zip>80122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The George Washington Universtiy Medical Facility</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Research Associates, LLC</name>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shrock Orthopedic Research</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Institute of Louisiana</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greater Baltimore Neurosurgical Associates at GBMA</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sports Medicine North</name>
      <address>
        <city>Peabody</city>
        <state>Massachusetts</state>
        <zip>01960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Low Back and Neck Care</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedics Associates of the Greater Lehigh Valley</name>
      <address>
        <city>Phillipsburg</city>
        <state>New Jersey</state>
        <zip>08865</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Care and Rehabilitation, Inc.</name>
      <address>
        <city>Roseland</city>
        <state>New Jersey</state>
        <zip>07068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center, Dept. of Neurological Surgery</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Upstate Medical Universtiy-Department of Orthopedics- Institute for Spine Care</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triangle Orthopaedic Associates</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NeuroSpine Institute, LLC</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Performance Spine and Sports Physicians</name>
      <address>
        <city>Pottstown</city>
        <state>Pennsylvania</state>
        <zip>19464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OrthopaediCare (Abington Orthopaedic Specialists)</name>
      <address>
        <city>Willow Grove</city>
        <state>Pennsylvania</state>
        <zip>19090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New England Center for Clinical Research</name>
      <address>
        <city>Cranston</city>
        <state>Rhode Island</state>
        <zip>02920</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Tennessee Brain &amp; Spine Center</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Back Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedics International Spine</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center for Pain Relief, Inc</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 4, 2008</study_first_submitted>
  <study_first_submitted_qc>June 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2008</study_first_posted>
  <results_first_submitted>August 10, 2020</results_first_submitted>
  <results_first_submitted_qc>August 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 25, 2020</results_first_posted>
  <last_update_submitted>November 12, 2020</last_update_submitted>
  <last_update_submitted_qc>November 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 19, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT00692276/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>1 - Study Treatment</title>
          <description>Interspinous Process Spacer Device&#xD;
Superion™ Interspinous Spacer: Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
        </group>
        <group group_id="P2">
          <title>2 - Active Control Treatment</title>
          <description>Interspinous Process Spacer Device&#xD;
X-STOP® IPD® Device: Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Randomized Population</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="190"/>
                <participants group_id="P2" count="201"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="190"/>
                <participants group_id="P2" count="201"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Completed 24 Months</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="190"/>
                <participants group_id="P2" count="201"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="183"/>
                <participants group_id="P2" count="187"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1 - Study Treatment</title>
          <description>Superion™ Interspinous Spacer</description>
        </group>
        <group group_id="B2">
          <title>2 - Active Control Treatment</title>
          <description>X-STOP® IPD® Device</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="190"/>
            <count group_id="B2" value="201"/>
            <count group_id="B3" value="391"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.9" spread="9.4"/>
                    <measurement group_id="B2" value="66.2" spread="10.2"/>
                    <measurement group_id="B3" value="66.5" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="152"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                    <measurement group_id="B2" value="129"/>
                    <measurement group_id="B3" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="185"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="375"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects With Clinically Significant Improvement in Outcomes</title>
        <description>Where clinically significant improvement in outcomes compared to baseline, as determined by meeting the following:&#xD;
At least two of three domains of the Zurich Claudication Questionnaire (ZCQ) [validated, condition-specific patient-reported questionnaire that captures data in three distinct domains]&#xD;
Improvement in physical function by ≥0.5 points&#xD;
Improvement in symptom severity by ≥0.5 points&#xD;
&quot;Satisfied&quot; or &quot;somewhat satisfied&quot; as defined by a score of ≤ 2.5 points on the patient satisfaction domain&#xD;
No re-operations, revisions, removals or supplemental fixation at the index level(s)&#xD;
No major implant- or procedure-related complications:&#xD;
No dislodgement, migration, or deformation&#xD;
No new or persistent worsened neurological deficit at the index level&#xD;
No spinous process fractures&#xD;
No deep infection, death, or other permanent device attributed disability&#xD;
No clinically significant confounding treatments:&#xD;
No epidural injections or nerve block proc</description>
        <time_frame>Baseline and 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>1 - Study Treatment</title>
            <description>Interspinous Process Spacer Device&#xD;
Superion™ Interspinous Spacer: Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
          </group>
          <group group_id="O2">
            <title>2 - Active Control Treatment</title>
            <description>Interspinous Process Spacer Device&#xD;
X-STOP® IPD® Device: Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Clinically Significant Improvement in Outcomes</title>
          <description>Where clinically significant improvement in outcomes compared to baseline, as determined by meeting the following:&#xD;
At least two of three domains of the Zurich Claudication Questionnaire (ZCQ) [validated, condition-specific patient-reported questionnaire that captures data in three distinct domains]&#xD;
Improvement in physical function by ≥0.5 points&#xD;
Improvement in symptom severity by ≥0.5 points&#xD;
&quot;Satisfied&quot; or &quot;somewhat satisfied&quot; as defined by a score of ≤ 2.5 points on the patient satisfaction domain&#xD;
No re-operations, revisions, removals or supplemental fixation at the index level(s)&#xD;
No major implant- or procedure-related complications:&#xD;
No dislodgement, migration, or deformation&#xD;
No new or persistent worsened neurological deficit at the index level&#xD;
No spinous process fractures&#xD;
No deep infection, death, or other permanent device attributed disability&#xD;
No clinically significant confounding treatments:&#xD;
No epidural injections or nerve block proc</description>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="183"/>
                <count group_id="O2" value="187"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.7"/>
                    <measurement group_id="O2" value="50.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>60 Months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>1 - Study Treatment</title>
          <description>Interspinous Process Spacer Device&#xD;
Superion™ Interspinous Spacer: Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
        </group>
        <group group_id="E2">
          <title>2 - Active Control Treatment</title>
          <description>Interspinous Process Spacer Device&#xD;
X-STOP® IPD® Device: Implantation of interspinous process spacer to treat lumbar spinal stenosis</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="190"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="190"/>
                <counts group_id="E2" subjects_affected="117" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Coronary Episode, Ischemic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="190"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Cardiovascular</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="190"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Gastrointestional Bleed</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Loss of bowel control</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="190"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <description>Other Adverse Events include events not fitting an existing adverse event category, including insomnia, psychological disorder, weight loss, general weakness, ganglion cysts, and drug withdrawal</description>
                <counts group_id="E1" events="48" subjects_affected="37" subjects_at_risk="190"/>
                <counts group_id="E2" events="38" subjects_affected="30" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Device dislodgement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Device migration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Device subsidence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Genitiurinary</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="190"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gallstones</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic Reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Deep Infection at the Operative Site</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="190"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Respiratory Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Soft Tissue Damage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Spinous Process Fracture</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="190"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Vertebral Compression Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence or Delayed Healing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Injury, accidental</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="190"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="190"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Pain - Buttock or Groin</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="190"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Presence of Osteophyte Formation associated with Severe Disc or Facet Degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Spinal Stenosis Symptoms at Index Level</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="190"/>
                <counts group_id="E2" events="19" subjects_affected="18" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Leg pain</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="190"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Adjacent level degenerative disk disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Adjacent level stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="190"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Pain - buttock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer/neoplasm</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="190"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebrovascular Accident (CVA)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Dural Leak</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="190"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Neurological Disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="190"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Transient Ischemic Attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Sensory loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary Edema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Respiratory Disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease (COPD)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Wound Drainage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="190"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="82" subjects_at_risk="190"/>
                <counts group_id="E2" subjects_affected="100" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular</sub_title>
                <counts group_id="E1" events="25" subjects_affected="20" subjects_at_risk="190"/>
                <counts group_id="E2" events="20" subjects_affected="16" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine/Metabolic</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="190"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Genitourinary</sub_title>
                <counts group_id="E1" events="25" subjects_affected="22" subjects_at_risk="190"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <description>Other Adverse Events including events not fitting a specific adverse event category, including insomnia, psychological disorder, weight loss, general weakness, ganglion cysts, and drug withdrawal</description>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="190"/>
                <counts group_id="E2" events="10" subjects_affected="5" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="190"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="108" subjects_affected="78" subjects_at_risk="190"/>
                <counts group_id="E2" events="100" subjects_affected="70" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Pain - Back</sub_title>
                <counts group_id="E1" events="56" subjects_affected="50" subjects_at_risk="190"/>
                <counts group_id="E2" events="71" subjects_affected="66" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Pain - Buttock and Groin</sub_title>
                <counts group_id="E1" events="23" subjects_affected="21" subjects_at_risk="190"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Pain - Leg</sub_title>
                <counts group_id="E1" events="41" subjects_affected="37" subjects_at_risk="190"/>
                <counts group_id="E2" events="54" subjects_affected="47" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Spinal Stenosis at Index Level</sub_title>
                <counts group_id="E1" events="37" subjects_affected="35" subjects_at_risk="190"/>
                <counts group_id="E2" events="38" subjects_affected="34" subjects_at_risk="201"/>
              </event>
              <event>
                <sub_title>Spinal Process Fracture</sub_title>
                <counts group_id="E1" events="24" subjects_affected="22" subjects_at_risk="190"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer/Neoplasm</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="190"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurological Disorder</sub_title>
                <counts group_id="E1" events="27" subjects_affected="22" subjects_at_risk="190"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steve Reitzler</name_or_title>
      <organization>Vertiflex</organization>
      <phone>442-325-5934</phone>
      <email>sreitzler@vertiflex.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

